Overview
- 43 inspections across 43 sites are on record.
- 105 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-04.
At a glance
Inspections
43
Sites
43
Observations
105
Career since
Aug 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Bachem Americas, Inc. | 4 May 2026 | Human Drugs | On file |
| Silgan Unicep Packaging, LLC | 2 Apr 2026 | Human Drugs | View 483 → |
| BioChem Sioux City Inc. | 19 Mar 2026 | Human Drugs | On file |
| Gilead Sciences, Inc. | 18 Feb 2026 | Human Drugs | On file |
| Pharmalogic Los Angeles, LLC | 5 Feb 2026 | Human Drugs | On file |
Sites inspected
Bachem Americas, Inc.Torrance, United States1 insp.
Silgan Unicep Packaging, LLCSpokane, United States1 insp.
BioChem Sioux City Inc.Sioux City, United States1 insp.
Gilead Sciences, Inc.La Verne, United States1 insp.
Pharmalogic Los Angeles, LLCLos Angeles, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Youkeun Kim5 shared
Crystal Monroy4 shared
Sangeeta M Khurana3 shared
Kham Phommachanh3 shared
Nicholas L Hunt2 shared
Heidy C Perales2 shared
Uttaniti Limchumroon2 shared
Elvis Patel1 shared
Gloria E Andia1 shared
Nathan E Hellman1 shared
Full investigator report
Get the verbatim findings behind Carolina D Vasquez's 105 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site